the insto placement was 6x over subscribed according to management which suggests fairly strong demand for the scrip at $72.50
Asia is largely untapped for BKL. Even if they get this partly right in their execution there is upside. But this is a medium/long term story. Take a look at its competitor, Swiss - they are shooting the lights out in China while BKL is (currently) lagging
